Impact of a Medicaid Copayment Policy on Prescription Drug and Health Services Utilization in a Fee-for-Service Medicaid Population

BACKGROUND: Copayments (copays) for prescription drugs are a common policy among state Medicaid programs. Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic disease. OBJECTIVES: The goal of this research was to quantify the impact of a copay policy for prescription drugs on medication and health services utilization overall and among subjects with several common chronic diseases enrolled in a state Medicaid program. RESEARCH DESIGN: Using aggregated pharmacy claims, segmented linear regression models were used to evaluate changes in overall and disease-specific pharmacy utilization after implementation of a copay policy. Trends in emergency department encounters, office visits, and hospitalizations were used to evaluate the impact of this policy on unintended consequences. Utilization among cohorts of patients with several chronic conditions were analyzed to determine if a differential response existed by drug indication. RESULTS: After copay implementation, utilization of prescription drugs declined significantly by 17.2% (P < 0.0001). This pattern was observed at varying degrees for all drug classes investigated. Rates of emergency department encounters, office visits, or hospitalizations did not increase after the policy was introduced. Subjects with diabetes, respiratory disease, and schizophrenia immediately reduced their use of nonindicated drugs significantly more than drugs indicated for their condition. CONCLUSIONS: Among Medicaid recipients, nominal copays are associated with significant reductions in use of clinically important drug classes. However, patients with chronic disease exhibited a differential response depending on the disease indication of the drug class

Copayment · Emergency department · Environmental health · Family medicine · Fee-for-service · Health care · Health insurance · Medicaid · Medical prescription · Population · Prescription drug · Psychiatry · Chronic Disease Management Strategies · Emergency Medicine · Medication Adherence and Compliance · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmacology · Pharmacy

• Sex, drugs and gender roles

  Open Access•Devon Greyson, Devon L Greyson et al.•International Journal for Equity…•2010

  Incluir item

• Medicaid coverage and use of nicotine replacement treatment

  Open Access•Lianlian Lei, Feng Liu•Economics & Human Biology•2020

  Incluir item

• Chronic Health Outcomes and Prescription Drug Copayments in Medicaid

  Dobrinka Kostova, Deliana Kostova et al.•Medical Care•2017

  Incluir item

• Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia

  Open Access•Aleksi Hamina, Antti Tanskanen et al.•Medical Care•2020

  Incluir item

• Validation of a combined comorbidity index

  Open Access•Mary E Charlson, Mary Charlson et al.•Journal of Clinical Epidemiology•1994

  Incluir item

• Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons

  Robyn Tamblyn•JAMA•2001

  Incluir item

• Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data

  Open Access•Patrick S Romano, L L Roos et al.•Journal of Clinical Epidemiology•1993

  Incluir item

• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

  Open Access•Richard A Deyo, R DEYO•Journal of Clinical Epidemiology•1992

  Incluir item

• Segmented regression analysis of interrupted time series studies in medication use research

  Open Access•Anita K Wagner, Stephen B Soumerai et al.•Journal of Clinical Pharmacy and…•2002

  Incluir item

• Prescription Drug Cost Sharing

  Dana P Goldman, Geoffrey F Joyce et al.•JAMA•2007

  Incluir item

• A new method of classifying prognostic comorbidity in longitudinal studies

  Open Access•Mary E Charlson, Peter Pompei et al.•Journal of Chronic Diseases•1987

  Incluir item

• The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services

  Arthur A Nelson, C Eugene Reeder et al.•Medical Care•1984

  Incluir item

• Medicaid Records as a Valid Data Source; The Tennessee Experience

  Charles F Federspiel, WAYNE A RAY et al.•Medical Care•1976

  Incluir item